Skip to main content

What's New

NIH
Watchful waiting reasonable for patients with diabetic macular edema and good vision People with good vision despite having center-involved diabetic macular edema can safely forego immediate treatment of their eye condition as long as they are closely monitored, and treatment begins promptly if vision worsens, according to clinical trial results. he findings are published online today in the Journal of the American Medical Association.
NIH
Gout treatment may help prevent obesity-related type 2 diabetes, suggests small NIH study The drug colchicine, used to treat the arthritic condition gout, could potentially reduce complications accompanying metabolic syndrome, a combination of high blood pressure, high blood sugar and other conditions that increase the risk of heart disease and type 2 diabetes, according to researchers at the National Institutes of Health. Their study appears in Diabetes, Endocrinology, and Metabolism.
NIH
This National Diabetes Month, care for your health after gestational diabetes Up to one in every 10 pregnancies in the United States is affected by gestational diabetes, a type of diabetes found for the first time when a woman is pregnant.
NIH
Gene mutation points to new way to fight diabetes, obesity, heart disease Researchers say they have discovered a gene mutation that slows the metabolism of sugar in the gut, giving people who have the mutation a distinct advantage over those who do not.
NIH
Gastric banding as effective as metformin in slowing progression of prediabetes, type 2 diabetes Half of BetaFat study participants underwent a gastric banding procedure, which narrows the upper part of the stomach to slow digestion.
NIH
New NIH reference book is one-stop resource for diabetes medical information Covering the spectrum of diabetes, the book describes data and trends in the United States, complications of diabetes and related conditions, and prevention and medical care, including outlining major diabetes research findings.
NIH
Diabetes in America, 3rd Edition Diabetes in America, 3rd Edition, is a compilation and assessment of epidemiologic, public health, clinical, and clinical trial data on diabetes and its complications in the United States.
NIH
Two diabetes medications don’t slow progression of type 2 diabetes in youth In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body’s ability to make insulin, according to results published online June 25 in Diabetes Care.
NIDDK
NIDDK Director's Update Spring 2018 At NIDDK, we are fortunate to have dedicated employees and volunteers who work tirelessly toward their shared commitment to the Institute’s mission. And it shows. In 2017, NIDDK ranked No. 1 among large institutes and centers across NIH in employee engagement, global satisfaction and other measures.
NIH
Islet transplantation improves quality of life for people with hard-to-control type 1 diabetes Quality of life for people with type 1 diabetes who had frequent severe hypoglycemia — a potentially fatal low blood glucose (blood sugar) level — improved consistently and dramatically following transplantation of insulin-producing pancreatic islets, according to findings published online March 21 in Diabetes Care.
Insulin Resistance Pioneer Gerald Reaven Dies Gerald (Jerry) Reaven, who made fundamental contributions to the study of insulin resistance, died last week (February 12). The longtime professor at Stanford University School of Medicine researched the role of insulin in diabetes, hypertension, and a plethora of other diseases.
NIH
Does infant formula affect development of type 1 diabetes? Feeding infants who are at risk for type 1 diabetes a formula with proteins that have been broken down didn’t affect their chance of developing the disease. The results disprove a hypothesis and suggest no change in current guidelines for type 1 diabetes prevention.